Showing results (61-70 of 10,181) with videos related to

Sort By:
Pageof 1,019
Molecular Pharmacology|March 1, 1985
Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptorS M Sherby, A T Eldefrawi, E X Albuquerque, et al.
Molecular Pharmacology|April 1, 1985
Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cellsG S Marks, D T Allen, C T Johnston, et al.
Molecular Pharmacology|February 1, 1985
Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptorS E Leff, I Creese
Molecular Pharmacology|February 1, 1985
A photoaffinity ligand for dopamine D2 receptors: azidocleboprideH B Niznik, J H Guan, J L Neumeyer, et al.
Molecular Pharmacology|February 1, 1985
Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell cultureK R Schwarz, S M Lanier, E A Carter, et al.
Molecular Pharmacology|February 1, 1985
Interaction of warfarin with human serum albumin. A stoichiometric descriptionF G Larsen, C G Larsen, P Jakobsen, et al.
Molecular Pharmacology|November 4, 2021
Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma CellsSean A Misek, Patrick A Newbury, Evgenii Chekalin, et al.
Molecular Pharmacology|November 4, 2021
Sex Differences in Cardiovascular Impact of Early Metabolic Impairment: Interplay between Dysbiosis and Adipose InflammationHaneen S Dwaib, Ibrahim AlZaim, Ghina Ajouz, et al.
Molecular Pharmacology|March 26, 2021
Substituted Cysteine Modification and Protection with n-Alkyl- Methanethiosulfonate Reagents Yields a Precise Estimate of the Distance between Etomidate and a Residue in Activated GABA Type A ReceptorsRyan J Fantasia, Anahita Nourmahnad, Elizabeth Halpin, et al.
Molecular Pharmacology|August 16, 2014
ABCD2 alters peroxisome proliferator-activated receptor α signaling in vitro, but does not impair responses to fenofibrate therapy in a mouse model of diet-induced obesityXiaoxi Liu, Jingjing Liu, Shuang Liang, et al.
Pageof 1,019